Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Second Genome (San Francisco, CA) a commercial-stage microbial profiling company designed to enable diagnostic/prognostic signatures and target identification, closed a $5M Series A financing. Participants include Advanced Technology Ventures, Morgenthaler Ventures, Wavepoint Ventures and Seraph Group. Thanx for your patience as we catch-up.

FORMA Therapeutics (Cambridge, MA) an oncology focused target discovery, screening, structural biology and small molecule developer, closed a $25M Series A funding financing. Participants include Novartis Option Fund and Bio*One Capital.

Biomics Biotechnologies (China) development-stage company focused on target identification and RNAi therapeutics, closed a $5M Series B financing. Participants include Jiangsu Dinghong Venture Capital and Jiangsu Benefit Rise Group.

Evolutionary Genomics (Lafayette, CO), a commercial-stage agricultural technology company with a proprietary gene discovery platform, closed a $3.0M Series A financing. Participants include Altira Group.


to top of page...